Clinical Trial: Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159620) titled 'Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients' on Aug. 26.

Brief Summary: ETP-ALL like patients have poor outcomes and prognosis, and the optimal therapeutic approaches are poorly characterized. The goal of this clinical trial is to evaluate the efficacy and safety of the venetoclax combined with azacitidine, chidamide, vindesine, and dexamethasone regimen in newly diagnosed ETP-ALL like patinets (including ETP-ALL, near ETP-ALL and T-ALL with myeloid mutations) .

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Adult T-cell Leukemia/Lymphom...